Corrigendum to “Enantioselective inhibitory abilities of enantiomers of notoamides against RANKL-induced formation of multinuclear osteoclasts” [Bioorg. Med. Chem. Lett. 27 (22) (2017) 4975–4978] (S0960894X17309927) (10.1016/j.bmcl.2017.10.017))

Hikaru Kato; Aika Kai; Tetsuro Kawabata; James D. Sunderhaus; Timothy J. McAfoos; Jennifer M. Finefield; Yukihiko Sugimoto; Robert M. Williams; Sachiko Tsukamoto

doi:10.1016/j.bmcl.2018.06.013

Corrigendum to “Enantioselective inhibitory abilities of enantiomers of notoamides against RANKL-induced formation of multinuclear osteoclasts” [Bioorg. Med. Chem. Lett. 27 (22) (2017) 4975–4978] (S0960894X17309927) (10.1016/j.bmcl.2017.10.017))

Hikaru Kato
, Aika Kai
, Tetsuro Kawabata
, James D. Sunderhaus
, Timothy J. McAfoos
, Jennifer M. Finefield
, Yukihiko Sugimoto
, Robert M. Williams
, Sachiko Tsukamoto

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

The structure of (+)-Versicolamide C in Fig. 1 should be corrected as shown below.

Original language	English (US)
Pages (from-to)	2573
Number of pages	1
Journal	Bioorganic and Medicinal Chemistry Letters
Volume	28
Issue number	14
DOIs	https://doi.org/10.1016/j.bmcl.2018.06.013
State	Published - Aug 1 2018
Externally published	Yes

ASJC Scopus subject areas

Biochemistry
Molecular Medicine
Molecular Biology
Pharmaceutical Science
Drug Discovery
Clinical Biochemistry
Organic Chemistry

Access to Document

10.1016/j.bmcl.2018.06.013

Fingerprint

Dive into the research topics of 'Corrigendum to “Enantioselective inhibitory abilities of enantiomers of notoamides against RANKL-induced formation of multinuclear osteoclasts” [Bioorg. Med. Chem. Lett. 27 (22) (2017) 4975–4978] (S0960894X17309927) (10.1016/j.bmcl.2017.10.017))'. Together they form a unique fingerprint.

Cite this

Kato, H., Kai, A., Kawabata, T., Sunderhaus, J. D., McAfoos, T. J., Finefield, J. M., Sugimoto, Y., Williams, R. M., & Tsukamoto, S. (2018). Corrigendum to “Enantioselective inhibitory abilities of enantiomers of notoamides against RANKL-induced formation of multinuclear osteoclasts” [Bioorg. Med. Chem. Lett. 27 (22) (2017) 4975–4978] (S0960894X17309927) (10.1016/j.bmcl.2017.10.017)). Bioorganic and Medicinal Chemistry Letters, 28(14), 2573. https://doi.org/10.1016/j.bmcl.2018.06.013

Corrigendum to “Enantioselective inhibitory abilities of enantiomers of notoamides against RANKL-induced formation of multinuclear osteoclasts” [Bioorg. Med. Chem. Lett. 27 (22) (2017) 4975–4978] (S0960894X17309927) (10.1016/j.bmcl.2017.10.017)). / Kato, Hikaru; Kai, Aika; Kawabata, Tetsuro et al.
In: Bioorganic and Medicinal Chemistry Letters, Vol. 28, No. 14, 01.08.2018, p. 2573.

Research output: Contribution to journal › Comment/debate › peer-review

Kato, H, Kai, A, Kawabata, T, Sunderhaus, JD, McAfoos, TJ, Finefield, JM, Sugimoto, Y, Williams, RM & Tsukamoto, S 2018, 'Corrigendum to “Enantioselective inhibitory abilities of enantiomers of notoamides against RANKL-induced formation of multinuclear osteoclasts” [Bioorg. Med. Chem. Lett. 27 (22) (2017) 4975–4978] (S0960894X17309927) (10.1016/j.bmcl.2017.10.017))', Bioorganic and Medicinal Chemistry Letters, vol. 28, no. 14, pp. 2573. https://doi.org/10.1016/j.bmcl.2018.06.013

Kato H, Kai A, Kawabata T, Sunderhaus JD, McAfoos TJ, Finefield JM et al. Corrigendum to “Enantioselective inhibitory abilities of enantiomers of notoamides against RANKL-induced formation of multinuclear osteoclasts” [Bioorg. Med. Chem. Lett. 27 (22) (2017) 4975–4978] (S0960894X17309927) (10.1016/j.bmcl.2017.10.017)). Bioorganic and Medicinal Chemistry Letters. 2018 Aug 1;28(14):2573. doi: 10.1016/j.bmcl.2018.06.013

Kato, Hikaru ; Kai, Aika ; Kawabata, Tetsuro et al. / Corrigendum to “Enantioselective inhibitory abilities of enantiomers of notoamides against RANKL-induced formation of multinuclear osteoclasts” [Bioorg. Med. Chem. Lett. 27 (22) (2017) 4975–4978] (S0960894X17309927) (10.1016/j.bmcl.2017.10.017)). In: Bioorganic and Medicinal Chemistry Letters. 2018 ; Vol. 28, No. 14. pp. 2573.

@article{db5e841e64574ad5b426a180234481b1,

title = "Corrigendum to {\textquotedblleft}Enantioselective inhibitory abilities of enantiomers of notoamides against RANKL-induced formation of multinuclear osteoclasts{\textquotedblright} [Bioorg. Med. Chem. Lett. 27 (22) (2017) 4975{\textendash}4978] (S0960894X17309927) (10.1016/j.bmcl.2017.10.017))",

abstract = "The structure of (+)-Versicolamide C in Fig. 1 should be corrected as shown below.",

author = "Hikaru Kato and Aika Kai and Tetsuro Kawabata and Sunderhaus, \{James D.\} and McAfoos, \{Timothy J.\} and Finefield, \{Jennifer M.\} and Yukihiko Sugimoto and Williams, \{Robert M.\} and Sachiko Tsukamoto",

note = "Publisher Copyright: {\textcopyright} 2018 Elsevier Ltd",

year = "2018",

month = aug,

day = "1",

doi = "10.1016/j.bmcl.2018.06.013",

language = "English (US)",

volume = "28",

pages = "2573",

journal = "Bioorganic and Medicinal Chemistry Letters",

issn = "0960-894X",

publisher = "Elsevier Ltd",

number = "14",

}

TY - JOUR

T1 - Corrigendum to “Enantioselective inhibitory abilities of enantiomers of notoamides against RANKL-induced formation of multinuclear osteoclasts” [Bioorg. Med. Chem. Lett. 27 (22) (2017) 4975–4978] (S0960894X17309927) (10.1016/j.bmcl.2017.10.017))

AU - Kato, Hikaru

AU - Kai, Aika

AU - Kawabata, Tetsuro

AU - Sunderhaus, James D.

AU - McAfoos, Timothy J.

AU - Finefield, Jennifer M.

AU - Sugimoto, Yukihiko

AU - Williams, Robert M.

AU - Tsukamoto, Sachiko

PY - 2018/8/1

Y1 - 2018/8/1

N2 - The structure of (+)-Versicolamide C in Fig. 1 should be corrected as shown below.

AB - The structure of (+)-Versicolamide C in Fig. 1 should be corrected as shown below.

UR - https://www.scopus.com/pages/publications/85048259897

UR - https://www.scopus.com/pages/publications/85048259897#tab=citedBy

U2 - 10.1016/j.bmcl.2018.06.013

DO - 10.1016/j.bmcl.2018.06.013

M3 - Comment/debate

C2 - 29903661

AN - SCOPUS:85048259897

SN - 0960-894X

VL - 28

SP - 2573

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

IS - 14

ER -

Corrigendum to “Enantioselective inhibitory abilities of enantiomers of notoamides against RANKL-induced formation of multinuclear osteoclasts” [Bioorg. Med. Chem. Lett. 27 (22) (2017) 4975–4978] (S0960894X17309927) (10.1016/j.bmcl.2017.10.017))

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this